Stehr M, Schuster T, Pepperl S, Wallner C-P, Dietz H-G
Kinderchirurgische Klinik, Dr. v. Haunersches Kinderspital, Ludwig-Maximilians-Universität München, München, Germany.
Eur J Pediatr Surg. 2004 Feb;14(1):45-50. doi: 10.1055/s-2004-815780.
The treatment of vesicoureteral reflux (VUR) is still a controversial issue. The efficacy of medical treatment appears to be equal to that of operative procedures in avoiding new formation of renal scars. However, there are generally accepted indications for operative procedures including bilateral high-grade VUR, especially in young patients. Ureteral reimplantation (UCN) is the operative treatment of choice in cases with high-grade VUR. Alternatively in cases with lower-grade VUR, injection of bulking agents under the refluxive orifice can be performed. It is also generally accepted that UCN with extravesical preparation of the ureter and the bladder should not be done bilaterally in a one-stage procedure. Postoperative bladder dysfunction may result due to detrimental neurogenic effects. In this study we report on our operative procedure in cases with bilateral high-grade VUR, during which we perform intra/extravesical UCN (mod. Leadbetter-Politano) of the higher-grade refluxive ureter, and (open) subureteral collagen injection (SCIN) of the lower-grade refluxive orifice as a combined one-stage procedure. In this study 50% of the patients had no VUR on either side after the first combined procedure. 15% of the patients showed significant down-grading of VUR of the injected side. These patients underwent a 2nd endoscopic SCIN. 35% of the patients showed no change of VUR of the injected side after the first procedure; these patients underwent reimplantation of this side in another operation. Accordingly, 50% of patients with bilateral high-grade VUR required a 2nd operative procedure under full anesthesia to achieve loss of VUR on both sides. None of the patients showed bladder dysfunction postoperatively. Mean follow-up after the last operative correction was 29.9 months (6 - 84 months).
膀胱输尿管反流(VUR)的治疗仍是一个存在争议的问题。在避免新的肾瘢痕形成方面,药物治疗的效果似乎与手术治疗相当。然而,手术治疗有一些普遍认可的适应证,包括双侧重度VUR,尤其是在年轻患者中。输尿管再植术(UCN)是重度VUR病例的首选手术治疗方法。对于轻度VUR病例,可选择在反流口下方注射填充剂。一般也认为,不应在一期手术中双侧进行输尿管膀胱外准备的UCN,因为术后可能会因有害的神经源性影响而导致膀胱功能障碍。在本研究中,我们报告了双侧重度VUR病例的手术方法,即对重度反流的输尿管进行膀胱内/膀胱外UCN(改良Leadbetter-Politano法),对轻度反流的开口进行(开放式)输尿管下胶原蛋白注射(SCIN),作为一期联合手术。在本研究中,50%的患者在首次联合手术后双侧均无VUR。15%的患者注射侧的VUR有显著降级,这些患者接受了第二次内镜SCIN。35%的患者在首次手术后注射侧的VUR无变化,这些患者在另一次手术中对该侧进行了再植术。因此,50%的双侧重度VUR患者需要在全身麻醉下进行第二次手术,以实现双侧VUR消失。所有患者术后均未出现膀胱功能障碍。最后一次手术矫正后的平均随访时间为29.9个月(6 - 84个月)。